Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Operating Expenses (2019 - 2025)

Pulmonx (LUNG) has disclosed Operating Expenses for 7 consecutive years, with $30.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses rose 4.42% to $30.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $124.4 million, a 6.28% increase, with the full-year FY2024 number at $119.7 million, up 6.23% from a year prior.
  • Operating Expenses was $30.4 million for Q3 2025 at Pulmonx, down from $32.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $32.0 million in Q2 2025 to a low of $19.1 million in Q1 2021.
  • A 5-year average of $26.7 million and a median of $28.2 million in 2023 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: soared 73.16% in 2021, then rose 3.37% in 2024.
  • Pulmonx's Operating Expenses stood at $22.6 million in 2021, then grew by 14.12% to $25.8 million in 2022, then grew by 9.72% to $28.3 million in 2023, then increased by 9.49% to $31.0 million in 2024, then fell by 1.81% to $30.4 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Operating Expenses are $30.4 million (Q3 2025), $32.0 million (Q2 2025), and $30.9 million (Q1 2025).